If over-the-counter antihistamines aren’t effective for you, your doctor may recommend H2 blockers, steroids, biologics, or ...
Zavodnick told Pharmaceutical Technology that Excellergy plans to initiate an ex-US Phase I study of its lead ECRI candidate, ...
A brand-new drug has been approved that tackles moderate to severe hot flashes without using hormones. Called elinzanetant ...
Sales growth was driven by continued strong execution on priority brands including Kisqali (+68% cc), Kesimpta (+44% cc), Pluvicto (+45% cc) and Scemblix (+95% cc) Core operating income margin 1 was ...
The drug, elinzanetant, is expected to be available in the United States beginning in November under the brand name Lynkuet, ...